Market Access and Reimbursement
Professional resources for coverage, coding, prior authorization, and payer information for the Vibrant System™.
Product and Coding Information
Essential coding, classification, and pricing details for the Vibrant System™
Indications for Use
The Vibrant System™ is an orally administered Capsule that is indicated for the treatment of adults with chronic idiopathic constipation who have not experienced relief of their bowel symptoms by using laxative therapies at the recommended dosage for at least one month.
View Instructions for Use (IFU)FDA Clearance
| Authorization | Date |
|---|---|
| DEN210052 | August 26, 2022 |
| K223031 | January 13, 2023 |
Billing and Coding
| Product Description | Legacy FDA Identification Number (NDC-like number) | GTIN 14# | # of Units / Package | List Price (WAC) |
|---|---|---|---|---|
| Vibrant System™ Starter Kit | 60009-0189-82 | 00860009189829 | (1) Reuseable Pod, (1) AC/DC Adapter, (1) USB Cable, (20) Disposable Capsules (Monthly Supply) | $1,350 USD |
| Vibrant Capsules | 60009-0189-80 | 00860009189805 | (20) Disposable Capsules (Monthly Supply) | $650 USD |
| A9268 | Programmer for transient, orally ingested capsule |
| A9269 | Programable, transient, orally ingested capsule, for use with external programmer, per month |
| K59.04 | Chronic idiopathic constipation |
Collected 2/2026 and subject to change.
This information is not a promise of coverage or payment. It is not intended to give reimbursement advice or increase reimbursement by any payer. Legal requirements and plan information can be updated frequently. Contact the plan for more information about current coverage, reimbursement policies, restrictions, or requirements that may apply.
For more information on ICD-10, visit Source: ICD-10 Code for Constipation — K59.0 — Codify by AAPC
Disclaimer: The information provided on this page is intended for educational purposes only and does not constitute a guarantee of insurance coverage or reimbursement. Coverage decisions are made by individual payers and may vary. All coverage information is subject to change without notice. Healthcare providers are responsible for verifying coverage with the applicable insurance plan. Vibrant Gastro does not approve, deny, or influence coverage determinations.
Healthcare Professional Access
For Physicians, Nurse Practitioners, and Physician Assistants: Enter your NPI number to access coverage information, downloadable forms, and payer resources.
Your NPI is used for verification purposes only. No data is stored or shared.
Coverage Overview
Current payer coverage for the Vibrant System™ across the United States
| Benefit Type | Plan Name | Coverage Type | States |
|---|
Coverage information is provided for educational purposes only and is not a guarantee of reimbursement. For details regarding specific insurance policy or plan, please refer to the insurer's website found on the members insurance card.
Forms and Templates
Ready-to-use documents for prior authorization, appeals, and medical necessity
Prior Authorization Checklist
Step-by-step checklist for initiating prior authorization requests.
Prior Authorization Example
Sample prior authorization request form with age, diagnosis, and policy guideline requirements.
Letter of Medical Necessity
Template letter supporting authorization requests for the Vibrant System™ treatment.
Letter of Appeal
Template appeal letter for denied coverage decisions, including medical history and rationale sections.
Appeal Process Checklist
Comprehensive checklist for navigating the appeals process after a coverage denial.
Important Notice: The information, forms, and resources provided above are for informational and administrative use only. They do not constitute medical advice, coverage guarantees, or financial advice. All coverage and reimbursement decisions are made solely by individual insurance plans and payers. Vibrant Gastro does not control or influence these decisions. Healthcare providers must verify coverage, eligibility, and any prior authorization requirements directly with the applicable insurance plan before providing care.
Clinical Evidence for the Vibrant System™
Request Clinical Evidence
As a subscriber to FormularyDecisions, Vibrant Gastro, Inc. is pleased to share information about Vibrant System™ to support healthcare decision-makers' Medical Policy and Pharmacy and Therapeutics Committee review process.
If you are already a registered user with FormularyDecisions, please log in to your account and search for Vibrant System™ to find all the available resources pertaining to the product.
Not yet a FormularyDecisions user?
FormularyDecisions is free to eligible HCDMs. If you are an HCDM but not yet a member of FormularyDecisions, you can register by visiting FormularyDecisions.com and clicking on the "Sign Up" button at the top of the web page. To register, all you need is to provide basic information that will be verified by the FormularyDecisions team. You will receive an email notification when your registration is approved, and then you can access FormularyDecisions to view information on Vibrant System™ and more!
Clinical Evidence Timeline
Published clinical trial data and real-world evidence supporting the Vibrant System™
Real-World Evidence of the Long-Term Clinical Utility of a Vibrating Capsule in the Management of Chronic Idiopathic Constipation
Real-world evidence from 1,722 patients with 491 and 298 who took Vibrant Capsule for 3 and 6 months respectively. Published November 2025.
View PublicationThe Vibrating Capsule: Safety and Tolerability in Patients with Chronic Idiopathic Constipation
Comprehensive safety and tolerability profile analysis of the vibrating capsule treatment. Published March 10, 2025.
View PublicationCost-Effectiveness of Vibrant System vs. Linaclotide in Chronic Idiopathic Constipation
Health economic analysis demonstrating cost-effectiveness compared to established pharmaceutical treatments. Published November 11, 2024.
View PublicationEffects of Treatment with a Vibrating Capsule in Patients with Severe Chronic Constipation
Pivotal study Post Hoc analysis demonstrating increased efficacy in severe CIC patients. Published August 09, 2024.
View PublicationRandomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation
Pivotal study addressing both efficacy and safety at a population-large scale. The Phase 3 RCT that established the foundation for FDA clearance. Published June 2023.
View PublicationDisclaimer: The information provided on this page is intended for educational purposes only and does not constitute a guarantee of insurance coverage or reimbursement. Coverage decisions are made by individual payers and may vary. All coverage information is subject to change without notice. Healthcare providers are responsible for verifying coverage with the applicable insurance plan. Vibrant Gastro does not approve, deny, or influence coverage determinations.
Contact Vibrant
